Literature DB >> 485888

The variable natural history of subacute sclerosing panencephalitis: a study of 118 cases from the Middle East.

W S Risk, F S Haddad.   

Abstract

A variable natural history was found in a standardized follow-up study of 118 patients with subacute sclerosing panencephalitis (SSPE). Only 20% followed the sequence:behavior change, mental deterioration, periodic attacks, severe debility, and death within a year. Six stages were identified: 0, subtle psychointellectual symptoms; 1, obvious psychointellectual and neurological changes; 2, stereotyped attacks; 3, vegetative psychomotor condition; 4, improvement; 5, relapse. Illness began in stage 0 for 32%; 1, 36%; 2, 19%; 1 and 2 simultaneously, 13%. In early development, 77% were hyperactive, and 27% had psychointellectual difficulties one to five years prior to obvious illness. The average duration of each stage was as follows: stage 0, two years; 1, 2.5 months; 2, 7.5 months; 3, 5.5 months; 4, 3.5 years; 5, 1.5 years. Noteworthy improvements and plateaus occurred in more than half of the patients. In stage 4, improvement was long-term and substantial for 5% and modest for 18%. Survival followed an exponential curve with an average half-life of 1.8 years; 41% of the patients survived beyond two years. Half of the patients passed through neither stage 0 nor stage 4; their half-life was 0.7 years. The remainder had a half-life of 3.0 years.

Entities:  

Mesh:

Year:  1979        PMID: 485888     DOI: 10.1001/archneur.1979.00500460044004

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  19 in total

1.  Resolving MRI abnormalities with progression of subacute sclerosing panencephalitis.

Authors:  J B Winer; M Pires; A Kermode; L Ginsberg; M Rossor
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 2.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

3.  Case of the month.

Authors:  P Wingenfeld; B Schmidt; U Querfeld; D Michalk
Journal:  Eur J Pediatr       Date:  1996-03       Impact factor: 3.183

4.  Epilepsia partialis continua in children with fulminant subacute sclerosing panencephalitis.

Authors:  Ruzica Kravljanac; Nebojsa Jovic; Milena Djuric; Ljubica Nikolic
Journal:  Neurol Sci       Date:  2010-10-30       Impact factor: 3.307

5.  Long-term survival of a case of subacute sclerosing panencephalitis.

Authors:  C R Barraclough
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-05       Impact factor: 10.154

6.  Long survival in subacute sclerosing panencephalitis.

Authors:  W A Cobb; J Marshall; F Scaravilli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-02       Impact factor: 10.154

7.  Cellular and humoral immunity in subacute sclerosing panencephalitis.

Authors:  S S Dhib-Jalbut; A M Abdelnoor; F S Haddad
Journal:  Infect Immun       Date:  1981-07       Impact factor: 3.441

8.  A 16-year old male with cortical blindness and focal motor seizures.

Authors:  S M Katrak; A Mahadevan; Arun B Taly; S Sinha; S K Shankar
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

9.  Subacute sclerosing panencephalitis : diagnosis and drug treatment options.

Authors:  B Anlar
Journal:  CNS Drugs       Date:  1997-02       Impact factor: 5.749

10.  Toxic effect of intraventricular interferon-alpha in subacute sclerosing panencephalitis.

Authors:  C Cianchetti; A L Fratta; F Muntoni; G Marrosu; M G Marrosu
Journal:  Ital J Neurol Sci       Date:  1994-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.